Deletion of MyD88 in T-cells Improves Anti-Tumor Activity in Melanoma. Bayer AL, Padilla-Rolon D, Smolgovsky S, Hinds P, et al. Am J Pathol 2024 Mar 3:S0002-9440(24)00083-X. doi: 10.1016/j.ajpath.2024.

Read + Share

Amedeo Smart

Independent Medical Education

Bayer AL, Padilla-Rolon D, Smolgovsky S, Hinds P, et al. Deletion of MyD88 in T-cells Improves Anti-Tumor Activity in Melanoma. Am J Pathol 2024 Mar 3:S0002-9440(24)00083-X. doi: 10.1016/j.ajpath.2024.
PMID: 38442804